Mısırcı, S. Et Al. 2025. Does the Use of Denosumab in Combination with bDMARDs or tsDMARDs Increase the Risk of Infection in Patients with Osteoporosis and Inflammatory Rheumatic Diseases?. Journal of Clinical Medicine , vol.14, no.17 .

Mısırcı, S., Ekin, A., YAĞIZ, B., COŞKUN, B. N., Büyükuysal, M. Ç., DALKILIÇ, H. E., ... PEHLİVAN, Y.(2025). Does the Use of Denosumab in Combination with bDMARDs or tsDMARDs Increase the Risk of Infection in Patients with Osteoporosis and Inflammatory Rheumatic Diseases?. Journal of Clinical Medicine , vol.14, no.17.

Mısırcı, Salim Et Al. "Does the Use of Denosumab in Combination with bDMARDs or tsDMARDs Increase the Risk of Infection in Patients with Osteoporosis and Inflammatory Rheumatic Diseases?," Journal of Clinical Medicine , vol.14, no.17, 2025

Mısırcı, Salim Et Al. "Does the Use of Denosumab in Combination with bDMARDs or tsDMARDs Increase the Risk of Infection in Patients with Osteoporosis and Inflammatory Rheumatic Diseases?." Journal of Clinical Medicine , vol.14, no.17, 2025

Mısırcı, S. Et Al. (2025) . "Does the Use of Denosumab in Combination with bDMARDs or tsDMARDs Increase the Risk of Infection in Patients with Osteoporosis and Inflammatory Rheumatic Diseases?." Journal of Clinical Medicine , vol.14, no.17.

@article{article, author={Salim Mısırcı Et Al. }, title={Does the Use of Denosumab in Combination with bDMARDs or tsDMARDs Increase the Risk of Infection in Patients with Osteoporosis and Inflammatory Rheumatic Diseases?}, journal={Journal of Clinical Medicine}, year=2025}